{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:02:16Z","timestamp":1775084536918,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107626","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T17:52:55Z","timestamp":1411149175000},"page":"e107626","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Metabolomics Analysis and Modeling Suggest a Lysophosphocholines-PAF Receptor Interaction in Fibromyalgia"],"prefix":"10.1371","volume":"9","author":[{"given":"Pierluigi","family":"Caboni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Liori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Laura","family":"Santoru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Era","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Cacace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"F Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity","volume":"62","author":"F Wolfe","year":"2010","journal-title":"Arthritis Care Research"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/135100006X116628","article-title":"Total antioxidant capacity and the severity of the pain in patients with fibromyalgia","volume":"11","author":"O Altindag","year":"2006","journal-title":"Redox Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00296-005-0079-y","article-title":"Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns","volume":"26","author":"S Ozgocmen","year":"2006","journal-title":"Rheumatol Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e26915","DOI":"10.1371\/journal.pone.0026915","article-title":"Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma","volume":"6","author":"MD Cordero","year":"2011","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Oestvang J, Anthonsen MW, Johansen B (2011) LysoPC and PAF trigger arachidonic acid release by divergent signaling mechanisms in monocytes. J Lipids Article ID 532145, 11 pages; doi:10.1155\/2011\/532145","DOI":"10.1155\/2011\/532145"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1021\/pr070123j","article-title":"An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy","volume":"6","author":"AM Weljie","year":"2007","journal-title":"J Proteome Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.38021","article-title":"The impact of inflammation on metabolomic profiles in patients with arthritis","volume":"5","author":"SP Young","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a tool for cardiac research","volume":"8","author":"JL Griffin","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11708","article-title":"Metabolic phenotyping in clinical and surgical environments","volume":"491","author":"JK Nicholson","year":"2012","journal-title":"Nature"},{"key":"ref11","first-page":"S154","article-title":"The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses","volume":"23","author":"R Bennett","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"J Folch","year":"1957","journal-title":"J. Biol. Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/prot.21213","article-title":"Understanding the Regulation Mechanisms of PAF Receptor by Agonists and Antagonists: Molecular Modeling and Molecular Dynamics Simulation Studies","volume":"67","author":"C Gui","year":"2007","journal-title":"PROTEINS: Structure, Function, and Bioinformatics"},{"key":"ref14"},{"key":"ref15","unstructured":"Frisch MJ, Trucks GW; Schlegel HB; Scuseria GE; Robb MA, et al. (2004) Gaussian 03, Revision C.02. Wallingford CT.."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"J Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"GM Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"454125","DOI":"10.1088\/0953-8984\/22\/45\/454125","article-title":"Structural and dynamical properties of the porins OmpF and OmpC: insights from molecular simulations","volume":"22","author":"A Kumar","year":"2010","journal-title":"J Phys Condens Matter"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"JC Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/ci600406v","article-title":"Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space","volume":"47","author":"M Na\u00efm","year":"2007","journal-title":"J Chem Inf Model"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/S0021-9258(18)89023-8","article-title":"Substrate Specificity of Plasma Lysolecithin Acyltransferase and the Molecular Species of Lecithin Formed by the Reaction","volume":"260","author":"PV Subbaiah","year":"1985","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbalip.2006.05.008","article-title":"Plasma PAF-acetylhydrolase: An unfulfilled promise?","volume":"1761","author":"SA Karabina","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clinbiochem.2012.09.009","article-title":"Purine metabolites in fibromyalgia syndrome","volume":"46","author":"A Fais","year":"2013","journal-title":"Clin Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1074\/jbc.272.12.7846","article-title":"Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants","volume":"272","author":"I Ishii","year":"1997","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/JVI.68.7.4628-4635.1994","article-title":"Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin","volume":"68","author":"HA Gelbard","year":"1994","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.biochem.69.1.419","article-title":"Platelet-activating factor and related lipid mediators","volume":"69","author":"SM Prescott","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-7827(99)00016-8","article-title":"Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice","volume":"39","author":"S Ishii","year":"2000","journal-title":"Prog Lipid Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.1016\/S0021-9258(19)83523-8","article-title":"Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)","volume":"254","author":"CA Demopoulos","year":"1979","journal-title":"J. Biol. Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"20400","DOI":"10.1016\/S0021-9258(18)54936-X","article-title":"Molecular cloning and expression of platelet- activating factor receptor from human leukocytes","volume":"266","author":"M Nakamura","year":"1991","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0006-291X(05)81261-6","article-title":"Characterization of a human cDNA that encodes a functional receptor for platelet activating factor","volume":"180","author":"RD Ye","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.1016\/S0021-9258(19)50394-5","article-title":"The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog","volume":"267","author":"D Kunz","year":"1992","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jinorgbio.2012.12.004","article-title":"Synthesis, biochemical evaluation and molecular modeling studies of novel rhodium complexes with nanomolar activity against Platelet Activating Factor","volume":"120","author":"AB Tsoupras","year":"2013","journal-title":"J Inorg Biochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1248\/bpb.34.1159","article-title":"Platelet-Activating Factor and pain","volume":"34","author":"M Tsuda","year":"2011","journal-title":"Biol. Pharm. Bull"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pain.2004.07.016","article-title":"Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice","volume":"111","author":"K Morita","year":"2004","journal-title":"Pain"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pain.2008.01.030","article-title":"Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate-NO-cyclic GMP signalling in spinal cord in mice","volume":"138","author":"K Morita","year":"2008","journal-title":"Pain"},{"key":"ref36","first-page":"1","article-title":"Fibromyalgia from the perspective of neuropatic pain","volume":"75(s)","author":"RH Dworkin","year":"2005","journal-title":"J. Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e10467","DOI":"10.1371\/journal.pone.0010467","article-title":"Role of PAF Receptor in Proinflammatory Cytokine Expression in the Dorsal Root Ganglion and Tactile Allodynia in a Rodent Model of Neuropathic Pain","volume":"5","author":"S Hasegawa","year":"2010","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T12:39:49Z","timestamp":1650199189000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107626"}},"subtitle":[],"editor":[{"given":"Richard H.","family":"Barton","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107626","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}